tabolism: current and future clinical applications (French). Rev
Neurol 1999;155:903–926.
Vanhamme L, van den Boogaart A, Van Huffel S. Improved method
for accurate and efficient quantification of MRS data with use of
priori-knowledge. J Magn Reson 1997;129:35– 43.
van den Boogaart A, Van Hecke A, Van Huffel P, Graveron-Demilly
S, van Ormondt D, de Beer R. MRUI: a graphical user interface for
accurate routine MRS data analysis. In: Proceedings of the European Society of Magnetic Resonance in Medicine and Biology 13th
Annual Meeting, Prague 1996. p 318.
Nemenyi P. Distribution free multiple comparison. Ph.D. Thesis,
State University of New York, New York. 1963.
Davie CA, Barker GJ, Webb S, et al. Persistent functional deficit in
multiple sclerosis and autosomal dominant cerebellar ataxia is
associated with axonal loss. Brain 1995;118:1583–1592.
Cwick VA, Hanstock CC, Allen PS, Martin WRW. Estimation of
brainstem neuronal loss in amyotrophic lateral sclerosis with in
vivo proton magnetic resonance spectroscopy. Neurology 1998;50:
72–77.
Mascalchi M, Tosetti M, Plasmati R, et al. Proton magnetic resonance spectroscopy in an Italian family with spinocerebellar ataxia
type 1. Ann Neurol 1998;43:244 –252.
Castillo M, Kwock L, Mukherji SK. Clinical applications of proton
MR spectroscopy. AJNR Am J Neuroradiol 1996;17:1–15.
Provencher SW. Estimation of metabolite concentration from localized in vivo proton NMR spectra. Magn Reson Med 1993;30:672–
679.
Pouwels PJW, Frahm J. Regional metabolite concentrations in hu-man brain as determined by quantitative localized proton MRS.
Magn Reson Med 1998;39:53– 60.
Brooks WM, Friedman SD, Stidley CA.Reproducibility of 1H-MRS in
vivo. Magn Reson Med 1999;41:193–197.
Charles HC, Lazeyras F, Tupler LA, Krishnan KR. Reproducibility of
high spatial resolution proton magnetic spectroscopic imaging in
the human brain. Magn Reson Med 1996;35:606 – 610.
Hennig J, Pfister H, Ernst T, Ott D. Direct absolute quantification of
metabolites in the human brain with in vivo localized proton spectroscopy. NMR Biomed 1992;5:193–199.
Michaelis T, Merboldt KD, Bruhn H, Haniche W, Frahm J. Absolute
concentrations of metabolites in the adult human brain in vivo:
quantification of localized proton MR spectra. Radiology 1993;187:
219 –227.
Hetherington HP, Mason GF, Pan JW, et al. Evaluation of cerebral
gray and white matter metabolite differences by spectroscopic im-aging at 4.1 T. Magn Res Med 1994;32:565–571.
Tedeschi G, Righini A, Bizzi A, Barnett AS, Alger JR. Cerebral white
matter in the centrum semiovale exhibits a larger N-acetyl- signal
than does gray matter in long echo time 1H-magnetic spectroscopic
imaging. Magn Res Med 1995;33:127–133.
Doyle TJ, Bedell BJ, Narayana PA. Relative concentrations of proton MR visible neurochemicals in gray and white matter in human
brain. Magn Reson Med 1995;33:755–759.
Pfefferbaum A, Adalsteinsson E, Spielman D, Sullivan EV, Mil KO.
In vivo spectroscopic quantification of the N-acetyl moiety, creatine, and choline from large volumes of brain gray and white matter:
effects of normal aging. Magn Reson Med 1999;41:276 –284.
Kamada K, Houkin K, Hida K, et al. Localized proton spectroscopy
of focal brain pathology in humans: significant effects of edema on
spin-spin relaxation time. Magn Reson Med 1994;31:537–540.
Chistriansen P, Toft P, Larsson HBW, Stubgaard M, Henriksen O.
The concentration of N-acetyl aspartate, creatine phosphocreatine, and choline in different parts of the brain in adulthood and
senium. Magn Reson Imaging 1993;11:799 – 806.
Savoiardo M, Strada L, Girotti M, et al. Olivopontocerebellar atrophy: MR diagnosis and relationship to multisystem atrophy. Radiology 1990;174:693– 696.
Boesch SM, Schocke M, Burk K, et al. Proton magnetic resonance
spectroscopic imaging reveals differences in spinocerebellar ataxia
types 2 and 6. J Magn Reson Imag 2001;13:553–559.
Tedeschi G, Bertolino A, Massaquoi SG, et al. Proton magnetic
resonance spectroscopic imaging in patients with cerebellar degeneration. Ann Neurol 1996;39:71–78.
